首页 | 本学科首页   官方微博 | 高级检索  
   检索      

CHO细胞株开发技术策略探讨
作者姓名:陶维红  秦民民  张哲如
作者单位:上海津曼特生物科技有限公司, 上海 201210
基金项目:上海市科学技术委员会“科技型中小企业技术创新资金”项目(1402H195100)资助。
摘    要:主要介绍了单克隆抗体药物工业生产中宿主细胞选择、表达载体构建、转染方法、筛选技术、细胞培养工艺技术方法以及最后选定细胞株的标准等,结合单抗药物CHO细胞株开发和培养工艺的经验,对当前我国单抗CHO细胞株开发技术策略进行了探讨。

关 键 词:单克隆抗体  CHO细胞  细胞株开发  培养工艺    
收稿时间:2014-10-30

Strategy Discussion for CHO Cell Line Development
Authors:TAO Wei-hong  QIN Min-min  ZHANG Zhe-ru
Institution:Shanghai JMT-Bio Science & Technology Co. Lt., Shanghai 201210, China
Abstract:Several strategies for industrial production of monoclonal antibody drug were introduced in this paper, including host cell selection, construction of expression vector, transfection method, screening techniques, cell culture technology as well as the standard method of final cell lines selection. On the basis of the progress of monoclonal antibody drug CHO cell line development and cell culture process, current strategy for the development of CHO cell lines in monoclonal antibody technology were also discussed.
Keywords:monoclonal antibody  CHO cell  cell line development  cell culture process    
本文献已被 CNKI 等数据库收录!
点击此处可从《》浏览原始摘要信息
点击此处可从《》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号